Recruitment underway for a clinical trial testing new vaccine against respiratory viruses

Recruitment is underway for a clinical trial testing a vaccine candidate produced with The University of Queensland’s molecular clamp technology against life-threatening respiratory viruses.

Meitheal acquires rights to CONTEPO from Nabriva

The intravenous antibiotic has shown activity against multi-drug resistant strains causing complicated urinary tract infections. Credit: plo / Shutterstock. Meitheal Pharmaceuticals has expanded its biopharmaceutical

July 19, 2024

IDRx raises $120M for targeted GIST drug following leadership change

Under new leadership, IDRx has raised $120 million to push its targeted treatment for a rare digestive tract cancer through early-stage studies. The company plans

August 8, 2024

Pediatricians’ group reaffirms support for gender-affirming care while planning research review

The American Academy of Pediatrics reaffirmed its support for gender-affirming medical care for transgender children on Thursday, even as the treatments face a growing push for bans

August 4, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.